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ABSTRACT: Large-scale genetic databases are being developed in several countries 
around the world. However, these databases depend on public participation and 
acquiescence. In the past, information campaigns have been waged and little attention 
has been paid to dialogue. Nowadays, it is important to include the public in the 
development of scientific research and to encourage a free, open and useful dialogue 
among those involved. 
This paper is a review of community consultation strategies as part of four 
proposed large-scale genetic databases in Iceland, Estonia, United Kingdom and 
Quebec. The Iceland Health Sector Database and Estonian Genome Project have 
followed a “communication approach” in order to address public concerns, whereas, 
UK Biobank and Quebec CARTaGENE have chosen a “partnership approach” to 
involve the public in decision-making processes.  
Following a comparison of community consultation strategies, the main concerns 
of the public are examined as well as the challenges of involving communities. 
Importantly, reported across all groups is the concern for confidentiality, respect of the 
individual, transparency, and the donor’s right to access to their own result. However, 
even if researchers demonstrate a willingness to respect values such as fair 
representation, transparency and accountability, there is still a risk that the public will 
mistrust researchers and simply will not participate in sufficient numbers. 
Complications may arise when individual and community interests conflicts. The 
implementation of a partnership approach is definitely involving and costly; however, 
if used properly, this method can improve both participation and so database 
development.  
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Introduction 
 
Recent activity in genomics is spurring interest in the development of databanks. 
Large-scale genetic databases are currently being developed in several countries around 
the world. These databanks have been established with the aim of improving genetic 
epidemiological knowledge of common, complex diseases and of using this knowledge 
in the field of public health. Such endeavours are precedent-setting on several accounts. 
Large groups of selected individuals, varying in size from project to project, will be 
asked to volunteer DNA/blood samples for genetic analysis. The information will 
subsequently be used for medical research purposes in both public and private 
laboratories. The DNA samples will be linked to genealogical and personal health 
information in order to study the genetic as well as the environmental determinants of 
disease manifestation. Complex diseases have hitherto defied a simple genetic 
classification and are known to have important environmental factors as part of their 
aetiology. It is believed that by their scale, format and scope, these genomic databases 
will lead to clinically useful results and help medical research in a large number of 
diseases.1 But these efforts could also produce misinformation, or lead to misuse by 
organizations that might discriminate against people possessing what are perceived as 
less-than-optimal genetic profiles. These databases therefore represent a novel, high-
risk initiative that has the potential to produce breakthrough advances in genomics. In 
fact, these databases differ from the genetic registers of the past as well as from the 
gene-hunting research of today both because they are based on the general population, 
as opposed to particular patient groups or families, and because there is a great deal of 
information gathered about each individual, as well as information about the disease 
studied. 
Another change in the genomics research paradigm is the desire for public 
consultation. The controversies surrounding the first large-scale genetic database in 
Iceland emphasized the need for consultation at the outset of project development. In 
the past, the research community has taken a paternalistic “communication approach” 
when dealing with public concerns. However, some of the major population genetic 
projects that have arisen subsequent to the creation of the Icelandic database have taken 
a “partnership approach.” Consultations for public health research initiatives have 
usually addressed the concerns of academics, researchers, health care professionals, 
and/or special interest groups. Due to the scale of the contemporary public genetic 
databases, the consultations must include a large contingent of the general public and, 
importantly, in order for these projects to begin, it is necessary to have the general 
public’s acceptance. This need and desire for collaboration between academia and the 
broader public is unprecedented in general science endeavours, although it has been 
frequently used within the environmental science arena. These consultations are 
purported to be for the public’s benefit, not simply to solicit support. Thus, it is crucial 
that they be carried out in an unbiased, ethically sensitive way. 
A free, open and useful dialogue is encouraged, though it is not effortless to 
achieve. Yet, when dialogue is the method of consultation, the goal is to provide a 
forum for identifying and discussing issues, not necessarily for agreement or 
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consensus. The National Institutes of Health (NIH) defines community consultation as 
“a vehicle to listen to the community’s interests and concerns, to address ethical issues, 
and to communicate information about the research to the community.”2 It is important 
to keep in mind that community consultations are a consultative process, not a vote or 
referendum.3 In community consultation, the sponsors retain authority but consult with 
the public to obtain input that may influence and improve the decision-making 
process.4 
In fact, community consultation may help to identify pitfalls in the design or study 
plan. This may improve the project’s efforts to address issues of importance to the 
community and to yield meaningful data while working within distinct social and 
cultural contexts. As the NIH has indicated, community consultation may achieve goals 
not attainable through individual informed consent and standard ethics review: 
 
“Community members benefit from learning about the study and by understanding 
the scientific questions it seeks to answer, improving public scientific literacy. 
Also, members benefit by sharing results with a community after a study has been 
completed, research participants are more likely to know what to do to seek 
treatment or how to implement preventive measures to improve their health. 
Community consultation is also intended to elicit feedback regarding potential 
participants’ relevant values, preferences, concerns or judgments. As partners in, 
rather than simply as subjects of, the research activity, consultation increases the 
likelihood that community members will feel empowered rather than exploited.”2 
 
This paper examines the community consultation strategies component of four 
proposed large-scale genetic databases in Iceland, Estonia, the United Kingdom (UK) 
and Quebec. After a brief overview of the four genetic databases (I), their community 
consultation strategies are compared (II), and the main concerns of the public are 
examined (III), as well as the challenges of involving communities (IV). The paper 
concludes with some examples of the best ways to carry out community consultation. 
 
I:  Overview 
 
The Icelandic Health Sector Database, Estonian Genome Project, UK Biobank and 
Quebec CARTaGENE are all at different stages of development (Table 1, pp. 474-
475). The Icelandic Health Sector Database was assembled with initial approval 
from the Icelandic government in 1998 and with funding from a private company 
called deCODE Genetics. However, the database resource has yet to become fully 
operational.5 In 2001, the non-profit Estonian Genome Project Foundation was 
founded to oversee the establishment of the database with funding primarily from the 
Estonian government and international private investments.5 A pilot project to test the 
overall plan was initiated October 2002 and expanded to all of Estonia during 2003. In 
June 2002, the Wellcome Trust, Medical Research Council (MRC) and the UK 
Department of Health committed £25 million to UK Biobank.6 Pilot studies for their 
population genomics study began in early 2003. Finally, the Quebec CARTaGENE 
project, primarily funded for its “proof of concept” phase by the Réseau de Médecine 
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Génétique Appliquée (RMGA) of the Quebec Health Research Fund (FRSQ), is 
currently receiving approval and pilot funding from Genome Quebec and the Health 
Ministry (MSSS) of the Quebec government. 
 
Aims 
All of these large-scale genetic databanks have been established in order to find genes 
associated with common diseases. All of the databases will link lifestyle and personal 
health information to genotypes for use in scientific and public health research. The 
Icelandic and Estonian databanks will gather genetic information from a relatively 
homogeneous population whereas the Quebec and UK databanks will be examining 
genetic variation in large, heterogeneous populations. 
 
Size 
One aspect of these genetic databases that sets them apart from other types of 
previously developed databases is their size. The smallest of these is Quebec 
CARTaGENE which will include 1.5% of the province’s population, or 60-65,000 
individuals. The Icelandic database, next in size, theoretically could include about 
270,000 individuals; this number represents the entire population of the country and 
includes children as well as the deceased. The UK Biobank will consist of 500,000 
randomly selected adults and the largest will be the Estonian database which will 
include the entire population, that is, one million individuals. The large target number 
for each DNA bank is due to the nature of the intended research. Since the main focus 
of the databases is the genetics of complex diseases, the investigators involved are 
concerned with identifying important genotypes, environmental exposure and outcome 
interactions. A reliable quantification of these interactions requires large population-
based studies that correlate DNA variants across the genome with lifestyle information 
and the development of particular diseases.7 
 
Public resource 
All of the databases are public research resources. Only the Icelandic Health Sector 
Database has granted an exclusive license to a private company, deCODE Genetics, 
with access provided to the Icelandic Ministry of Health and by commercial 
subscription from other companies.8 While the Estonian Genome Project intends no 
exclusivity of access for public institutions, with regards to pharmaceutical and 
biotechnology companies, non-exclusive license agreements will be granted through 
their for-profit subsidiary, EGeen.9 The UK and Quebec DNA banks do not intend to 
have any exclusivity of access for any public or private laboratory. The only 
restrictions would be based on scientific and institutional review board (IRB) 
decisions. 
 
Consent, access to data and legislation 
Regarding the three topics of consent, access to data and legislation, the projects differ 
to varying degrees. All of the projects require informed consent in writing for all data 
and samples, except Iceland. The early controversy surrounding the Icelandic Health 
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Sector Database dealt with the issue of consent. The “volunteer’s” medical records and 
genealogical information are on the health database without consent. Icelanders must 
opt-out and be placed on an abstainers list in order to be excluded from entry into the 
database.8 This is seen by many to be a very weak form of consent especially since this 
option is not open to children and individuals with impaired competence.10 In Iceland, 
once consent is presumed, no additional consent is required for any subsequent use of 
the individual’s samples (“blanket” consent) obtained during medical care. Sampling 
specific to genetics research projects requires an explicit consent. 
In the case of the UK database, participants in the project will be consenting to 
“participate in UK Biobank,” and this consent will cover any project for which the data 
is subsequently used.11 Volunteers participating in the Quebec CARTaGENE project 
will give a general consent with additional consent for multi-layered options. A general 
consent will allow the anonymized use of data and biological materials; however, in 
order to provide benefits to participants from the semi-longitudinal approach, 
participants will be offered a variety of different choices.12 The Estonian project will 
require written informed consent for each use of a participant’s linked personal 
information (gene donor consent form).13 Children over the age of seven will be asked 
to participate in the Estonian Genome Project, with consent from their parents.  
If volunteers wish to withdraw from the database, or if they need to be recontacted 
for research and/or consent purposes, their personal information in the databank will 
need to remain coded and, therefore, cannot be completely anonymized. Under these 
circumstances, protection of donor confidentiality is usually addressed through the 
establishment of an independent body that controls the decoding of samples and the 
distribution of information to authorized researchers. Thus, the Quebec CARTaGENE 
project will be double-coded by the Quebec Health Insurance Board (RAMQ) and by 
CARTaGENE. The UK Biobank literature notes that the personal information of 
volunteers will be in a “reversibly anonymized” format. This format allows those with 
authorization to re-link the volunteer’s identifying information with the data and DNA 
samples via a code. The Icelandic database will contain anonymized information 
through unidirectional encryption, with no possibility of recontact, whereas, the 
Estonian database protocol states that the participants’ data will be coded only.  
The UK Biobank project makes clear in its literature that, while the participant’s 
data will be traceable to them, they will not have access to any of their own personal 
genetic or other research results. Essentially, the same situation exists in Iceland and 
Quebec. The Estonian Genome Project is the only project that explicitly states that 
donors upon request will have access to their personal data and research results. The 
other projects state that information will be available only at the general population 
level via normal peer-review processes in scientific journals or via press releases and 
will not be provided to the volunteers directly. 
No specific legislation governs the databanks in the UK and in Quebec. UK 
Biobank is covered by the Data Protection Act 1998 and the Human Rights Act 1998 
and common law. CARTaGENE is covered by the Quebec Civil Code and by Personal 
Information Access Legislation. In addition, the UK MRC has drafted guidelines on 
the use of biological samples and personal medical information.14 In Quebec the 
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RMGA drew up in 2000 a Statement of Principles on Human Genome Research15 as 
concerns individual/familial sampling which, in 2003, was followed by a Statement of 
Principles on the Ethical Conduct of Human Genetic Research in Populations16 and 
the Commission on Ethics in Science and Technology expressed an opinion on ethical 
issues raised by genetic databases for a responsible and democratic framework.17 The 
approach taken by the UK and Quebec reflects a preference to utilise existing 
legislation to govern large-scale databases and an historical tendency toward self-
regulation of medical research with minimal reliance on parliament. In contrast, 
Iceland and Estonia have taken the legislative approach by passing the Health Sector 
Database Act 1998 and the Human Genes Research Act 2000, respectively. The 
Icelandic Act for the Health Sector Database allows the Minister of Health, to grant a 
license to a private company for construction of an electronic database containing 
selected and coded data from the country’s health records. This Act also gives the 
company the right to exploit the data for commercial purposes. The Estonian Genome 
Project’s web page provides a different rationale for the establishment of the Human 
Genes Research Act. The objectives listed are: to regulate the maintenance of the 
database, to ensure the voluntary nature of gene donation, to ensure confidentiality of 
the identity of the gene donors and to protect individuals from the misuse of genetic 
data and discrimination (link to Human Genes Research Act).13 
 
II: Comparison of Community Consultation Strategies 
 
Community consultation is an increasingly common adjunct to genetics research, 
particularly for projects aiming to create large-scale genetic databases for use by 
multiple researchers, with numerous protocols, over an extended time period. Many 
factors motivate investigators to engage communities although it is not legally 
required. Due to the scale of these databases, the risk of group harm gives greater 
urgency to ensuring that communities understand the project, and to seeking their input 
regarding how the project and the groups are described. A process of ongoing dialogue 
facilitates greater comprehension and elicits a response to the potential concerns of 
participants.  
Regarding the four community consultation strategies examined, they vary among 
the four countries; however, they can be divided roughly into two types. Iceland and 
Estonia follow a communication type of approach using quantitative rather than 
qualitative measurements of public opinion. The UK and Quebec favor a public 
participation or partnership approach where analysis of public opinion is both 
quantitative and qualitative.  
 
Iceland 
In Iceland, cursory formal public discussion took place prior to the establishment of the 
Health Sector Database. The discussion consisted of 100 radio and TV programs and 
several town meetings across Iceland. After the programs and meetings had taken 
place, a survey indicated 75% support for the act and 25% against.18 In April 2000, a 
later poll showed 90% support for the database. However, this latter poll is considered 
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by some in Iceland to be unrepresentative. Petur Hauksson of Mannvernd (the 
Association of Icelanders for Ethics in Science and Medicine )stated that deCODE 
used misleading information in the poll, appealing to Icelanders to contribute to the 
global fight against disease, in the hope of recruiting support for their database.19,20 
A Data Protection Commission and Research Ethics Committee have been founded 
by the Icelandic government in order to address contentious issues, such as, access to 
genetic information by individuals and third parties and the exclusive license given to 
deCODE Genetics. Information about the database is freely available on the internet 
and the company deCODE has a web page sporting news releases, research initiatives 
and financial information.21 Alternatively, an international web forum has been 
established by the University of California at Berkeley and the University of Iceland.22 
Despite the attempts to not only provide information to the population via the media 
and the internet, but also to provide some modicum of debate, there still exists 
organised opposition in Iceland. The most vocal opposition is from “Mannvernd”. 
Whether this dispute is due to the legislation of a database act per se, or is a dispute 
over particular aspects of the Act, or both, is not clear. However, group members argue 
that the Act infringes on human rights. There are also concerns that a private company 
has a license to collect genetic, medical and genealogical information from the 
Icelandic population. Additionally, the Mannvernd web site has reported that as of June 
2003, 20426 individuals have chosen to opt out of the database, that is, over 10% of the 
Icelandic population.19 
 
Estonia 
The case of Estonia is somewhat different from Iceland although their approach to 
community consultation is similar. Although there has not been extensive public debate 
in Estonia beyond opinion polls, the country boasts a higher level of acceptance than 
seen in Iceland. Only 6% of the Estonian population are against the establishment of 
the database. The Estonian Genome Foundation has been careful to address issues of 
consent, confidentiality, trust, and discrimination. The Icelandic government and 
deCODE genetics have historically not been as attentive to these ethical concerns. This 
could explain the somewhat greater degree of acceptance in Estonia as opposed to 
Iceland. Also, there could be a sense that the Icelandic project, with its exclusive 
licence to a private company, is profit-driven and, comparatively, the Estonian project 
is geared toward public health since it is being provided as a public research resource. 
The Estonian Genome Project’s communication strategies tend toward the 
provision of scientific fact rather than open discussion of ethical and policy issues. The 
public in both Iceland and Estonia has not been provided a forum in which to discuss 
their concerns or to influence the direction of project development. Public opinion in 
these countries relies on Gallup poll results. 
The Estonian Genome Project’s web sites9,13 provide access to more information 
than the deCODE site. It is possible to view information on the Human Genes Research 
Act, including definitions of genetic terms, news items, as well as, questionnaires, and 
the results of current Gallup polls. Their web page states that the Estonian Genome 
Project aims to provide to all members of the Estonian population (whether a 
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participant in the project or not) general knowledge of genetics, either through the 
media or directly from a doctor. Also, all information connected with the establishment 
and functioning of the gene bank is to be made public. 
 
United Kingdom 
The project overseers involved with UK Biobank and CARTaGENE will carry out all 
of their community consultations using a partnership or collaborative approach. The 
model chosen by the UK and Quebec aims to address contentious issues through direct 
collaboration with the public. Attention will be focused on the proposed goal, i.e., 
efforts on behalf of the public so that the process will not be perceived to be used 
solely to provide a green light for researchers. 
The UK has already carried out several in-depth community consultations that 
address, either directly or indirectly, issues associated with the establishment of genetic 
databases. The consultations consist of focus groups, of various sizes, comprised of 
members of the general public and stakeholders (mostly doctors and nurses). Two early 
series of focus groups carried out in the spring of 2000, were designed to assess public 
attitudes toward scientific communication and genetic information, and were 
commissioned directly by the Welcome Trust (WT) and the MRC.23,24 A third set of 
focus groups initiated in the autumn of 2000, called “Public perceptions of human 
biological samples,” was directly related to UK Biobank and was carried out by a 
market research group.25 This first phase of community consultation was designed to 
inform policy-making, regarding which safeguards would be most acceptable to the 
public when establishing the large population cohort, and also to assess the likely 
public response to the proposed study.26 The researchers found that genetics was 
positively viewed when it was coupled to prevention and identification of genetic 
predisposition to disease. As a result of this third set of focus groups, the WT and the 
MRC were encouraged to focus on these positive associations so as to engender more 
support from the public, although some might construe this as manipulative.  
The latest Biobank consultation report, “UK Biobank: A question of trust” was 
published in March, 2002.27 This series of focus groups, funded by the MRC and the 
WT and carried out by an independent science policy consultancy, People, Science & 
Policy Limited (PSP), was composed of a variety of sessions: three sessions each 
involved 20 people aged 45 to 69 (the proposed age of volunteers for UK Biobank). In 
following sessions these groups of 20 were split into two smaller groups of 10 for an 
introductory meeting of 1.5 hours. The groups were then reconvened for a four-hour 
interactive workshop with PSP moderators and two members of the project team, one 
from the WT and the other from the MRC. This particular interactive discussion was 
carried out in order to explore and address questions about ethical and management 
issues surrounding the proposed UK Biobank project. Issues identified by the 
participants include recruitment, confidentiality, the governance of Biobank, “value for 
money”, data usage, thoughts on the name “UK Biobank”, and the need or not for 
further consultations. Additionally, an Ethics Consultation Workshop was carried out 
by the WT and MRC in the spring of 2002.28 Attitudes towards consent, 
confidentiality, security of data, commercialization and governance were solicited from 
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60 senior representatives of the biomedical sciences, clinical medicine, social science, 
ethics and the law. 
Despite these consultations, in the UK there is some organised opposition to the 
establishment of the UK Biobank. Critics claim that the British government is pushing 
ahead without a proper independent review of the validity of the science or safeguards 
for the public.29 GeneWatch UK, also questions the scientific validity of the database 
and is calling for a review of the project, independent of the MRC and WT.30 
Additionally, GeneWatch UK is concerned about the relationship between commercial 
interests and the databank and about the use of a general form of consent.11 Another 
group called the Human Genetics Alert believes the establishment of the database is 
premature because the ethical issues and purposes of UK Biobank have not been fully 
addressed by parliament or reviewed by the public.31 The Institute of Science in 
Society, located in London, criticizes the MRC and WT community consultation as 
being biased. It claims that many public concerns raised during the focus groups and 
interactive discussions are not being adequately addressed.32 
 
Quebec 
The consultation strategy of Quebec’s CARTaGENE project is at an earlier stage than 
the UK Biobank. Consultation is being carried out by two independant market research 
organisations. The target audience is the general public; the geographic area of 
influence is the province of Quebec, divided into 18 regions. Community consultation 
consists of three parts. The first, “Social Perceptions Research Platform,” was carried 
out during Autumn 2003 and contained a qualitative and quantitative phase. The 
purpose of the qualitative phase was to identify the social and ethical concerns of the 
public regarding the establishment of a large-scale genetic database. It consisted of 19 
focus groups of 7-8 individuals chosen randomly out of the phone book throughout 
Quebec’s population within four regions. Groups were distributed according to 
qualitative representative criteria: demographic, economic, linguistic, cultural and 
regional diversity. Four aspects were measured: perceptions and knowledge of 
genetics; enthusiasm for or fears about CARTaGENE; evaluation and understanding of 
communication tools; and deterrents and incentives to participating in CARTaGENE. 
Results indicate that the CARTaGENE Project is perceived to hold promise for all of 
society; to represent an important event with concrete spin-offs for society; and to be 
important for the future in terms of prevention and treatment of disease, and, therefore 
to have a of positive impact on the healthcare system. Nevertheless, individuals across 
all groups worried about confidentiality, transparency, and the right to access to their 
own result. Consequently, participation in the CARTaGENE Project would depend on 
a response to these concerns. 
The quantitative phase of Part I aimed to validate the results of the focus groups. 
This phase also aimed to evaluate public perceptions and attitudes towards the 
CARTaGENE Project and its communication strategy. A phone survey was conducted 
in all 18 regions. Among 1800 individuals, 76.9% agreed to participate in the survey. 
The same four aspects examined in the focus groups were measured. Results show that 
94% of respondents considered the CARTaGENE Project important for the Quebec 
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population. However, 19% of respondents thought that this Project was of little or no 
importance for them. In other respects, 80% of respondents showed enthusiasm for the 
Project. Finally, 19% of respondents considered that they would participate while 25% 
thought that they would probably not participate, especially among people not having 
completed grade 6. The probability of participating in CARTaGENE increased under 
various conditions: convenience of physical exam and blood sample (distance from 
personal residence), potential loss of time and income, disclosure of personal results to 
them, guaranteed confidentiality. Finally, 85% of respondents were in favor of a recall 
if CARTaGENE researchers needed it.  
Part two of the plan for community consultation includes several different methods 
that have been, or will be, implemented in Quebec. In June 2001 and June 2003, two 
workshops on the CARTaGENE Project and its ethical and legal aspects brought 
together professionals in ethics, law, decision and policy-making. Other techniques 
have been implemented to inform and involve citizens prior to and during the Project: 
web site access, newsletter publications, press releases and a toll-free hotline. 
Specifically, before the recruitment of Project participants starts, posters and 
information leaflets will be widely distributed, and during recruitment, information 
sessions will be organised (including all regions, indigenous peoples and ethno-cultural 
communities) to address/respond to questions raised by the population. The rationale 
for the different types of consultation is to promote an understanding of the science 
behind CARTaGENE and to engage the Quebec population in a constructive dialogue 
about the relationship between science and society. The web page is presently in 
operation, giving access to newsletters, press releases, and other documents.33 
Part three of the community consultation plan consists of a deliberative electronic 
forum. The motive for this process of community involvement is to provide a greater 
consideration of public opinion. As stated in the CARTaGENE research proposal, the 
public’s point of view cannot be achieved through information sessions only. A 
partnership approach requires consultations favoring exchanges between researchers 
and citizens to ensure that all opinions and views are taken into account. The 
deliberative web forum will ensure a continuing discussion and presentation of the 
public’s point of view. Any information gleaned from the electronic forum will be 
published.  
 
III:  Concerns of the Public 
 
The community consultation attempts of the UK have been the most extensive and will 
provide invaluable information for other groups. In the case of Iceland, the deCODE 
web page does not provide any information about the views of the Icelandic 
population, however, the opposition group, Mannvernd, does post particular concerns. 
Estonian public opinion is hard to gauge due to the fact that there has been minimal 
debate in that country. Yet as in Iceland, a law was adopted in a democratic parliament. 
Finally, the Quebec CARTaGENE project has carried out the first phase of its 
community consultation. This first phase draws a picture of the socio-cultural 
perceptions and intents of the Quebec population. 
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It is apparent, after the perusal of the references mentioned above, that particular 
public concerns are repeatedly mentioned.8,14,19-20,22,32 A synopsis was compiled of the 
main public concerns using information from the web pages of deCODE Genetics, 
Mannvernd and the Estonian Genome Project, the reports of the UK consultations, and 
the phase I results of the CARTaGENE consultation.. In general, it is believed that 
scientific research is admirable. Projects such as these large-scale genetic databases are 
seen to hold promise for the greater population. Importantly, however, reported across 
all groups, is the concern for confidentiality, respect of the individual, transparency, 
and the donor’s right to access to their own research result. 
 
Confidentiality and respect for the individual 
It appears that, in general, individuals are attracted by the idea of donation for the 
“greater good” but want to be assured that they will benefit from this donation and that 
their individuality will be respected. Not surprisingly, there is considerable concern 
about how employers or insurance companies might use human genetic information. 
Many fear that if others have access to their genetic information they will know too 
much about them. Genetics can be a very useful diagnostic tool but in most cases the 
diagnosis of disease, disability or condition depends on probabilities. It is not clear how 
accurate genetics will be as an indicator of individual health or disease. Irrespective of 
the probabilistic nature of such genetic information, the public needs reassurance that 
any results of research using genetic database information will be handled in a 
responsible way and that their best interests will be represented.  
 
Transparency 
Issues surrounding transparency were strongly voiced in the UK and Quebec, 
especially with regard to informed consent. Those in charge need to communicate why 
the sample collection is being set up, how the samples will be used, and to obtain 
consent for access to medical records. In keeping with the principle of transparency, it 
will be necessary to make clear to donors that their samples could be used in ways that 
are not currently known, following ethics review, especially when providing blanket 
consent. 
 
Access to research results 
Many members of the public expect that the results of research or tests will provide 
donors with a cornucopia of personal information and consider this a potential 
motivator for participation. In Quebec particularly, the response of participants of focus 
groups indicated that donors would be willing to forgo anonymization in favor of 
coding in order to gain access to personal test and research results. In addition, as noted 
in “UK Biobank: A question of trust,” the limitations of any research or testing must be 
made very clear. Donors need to know what sort of information will be provided on 
what sorts of diseases. 
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Public resource 
There are also two miscellaneous concerns that were mentioned in one or more of the 
projects. The Quebec population voiced strong support for public ownership of medical 
genetic databases and a concern for exclusivity of research resources. In Iceland, the 
Health Sector Database was founded without much reflection about the protection or 
consultation of the public. This resulted in a sense that the Icelandic government and 
the company, deCODE, had little respect for the well-being of the database donors. The 
founders of the project have had particular difficulty regaining the trust of members of 
the medical profession. After the establishment of the Icelandic database and the 
international evaluation of its operations, all subsequent large-scale genetic databases 
have developed their databases as public research resources paying serious attention to 
public opinion. 
A concern voiced by the public in both the UK and Iceland is the belief that 
research on human genetics is tampering with nature. They expressed anxiety about the 
possible misuse of samples via activities such as cloning or eugenics. In the UK, 
opposition apparently reflects the belief that public consultation was not conducted 
independently. There seems to be a sense that the WT and MRC were too much 
involved in the consultation process and they have been accused of “forum shopping”. 
In the UK, opposition groups are suspicious of the validity of the science for which the 
database is being created. Debate exists within the scientific and medical community as 
well. This kind of uncertainty about the risks and benefits of population genetics is 
usually avoided through community consultation. Withholding information, or not 
directly addressing contentious issues, can lead to mistrust. Opponents of the UK 
Biobank also complain that public concerns and ethical issues are being ignored in 
spite of the ethical enquiries undertaken by the funders of the UK Biobank.  
 
IV:  Challenges of involving communities 
 
Historically, public debate and scientific endeavour have existed in separate fields. The 
development of large-scale genetic databases around the world has played a role in 
bringing these two fields closer together. Due to the novelty of community consultation 
in areas of human genetics and the use of genetic information, a careful understanding 
of public opinion is needed. A shift from the Icelandic model to a more open public 
discussion and debate has occurred. This shift has culminated in the UK and Quebec 
community consultations where a variety of methods have been proposed and followed 
in order to gain a clearer understanding of public opinion. Scientific research is 
gradually being transformed from an independent and scholarly enterprise into a 
service for society. 
Community consultation is also presented as an avenue for the public to influence 
the direction of project development. It is thus important that those in charge indicate 
how public discussions have shaped a project. Unfortunately, the influence and impact 
of public discussion and debate have rarely been made explicit in any report or web-
based forum. For instance, in the report “UK Biobank: a question of trust,” 22 
recommendations are listed in the conclusion, however, the report does not indicate 
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whether any of these recommendations are being seriously examined. It is essential that 
UK Biobank provide follow-up information. The Human Genome Commission, Office 
of Science and Technology, and the House of Lords web pages have links to reports in 
which some recommendations from community consultation have been documented. 
However, any web-based access to documents is exclusionary since many individuals 
do not have access to computers. If an opinion is to be politically effective, one needs a 
considerable degree of commitment and organisation.34 In one of the UK consultation 
reports it was found that there is a lack of a framework within which people can access 
information about new science.24 There is a need for the creation of organisations with 
different perspectives to encourage a public dialogue. This lack of an experienced 
public voice makes it difficult to achieve the goals of community consultation. 
In Iceland, protests prompted creation of additional database safeguards such as the 
founding of a Monitoring Committee, Data Protection Commission and an 
Interdisciplinary Ethics Committee. The role of these regulatory bodies is to ensure that 
the running of the database conforms to the conditions and regulations of the Health 
Sector Database Act 1998.8 In addition, public debate in Iceland is improving and in 
late 2001 an agreement was reached between the official representatives of the medical 
profession, government and deCODE to proceed together for 12 years.5 
Comparatively, Estonia has been avoiding the problems encountered by Iceland. 
The country is eager to follow the ethical guidelines set out by the European Union. 
The Estonian Genome Foundation is becoming increasingly interested in involving the 
Estonian public. The Foundation has committed more resources to communication 
efforts through the media and has initiated a debate in the national newspapers on the 
risks and benefits of personalized medicine.35 
In the case of Quebec, through a deliberative electronic forum, CARTaGENE 
researchers, aim to provide an integrated, active and collective partnership approach, 
whereby the concerns and interests of citizens are taken into account. They also aim for 
transparency and openness at all levels. 
Even if researchers demonstrate a willingness to respect values such as fair 
representation, transparency and accountability, there is still a risk that the public will 
mistrust researchers and simply will not participate in sufficient numbers. Other 
projects involving DNA and data banking have failed because of public concerns: 
recently, the private company Autogen attempted to set up a genetic database 
composed of the population of Tonga, an island in the South Pacific. The Tongans 
opposed the establishment of the database because of concerns about informed consent, 
and the lack of public discussion.36 The project was halted. In the USA, the National 
Heart, Lung and Blood Institute refused, apparently on communitarian grounds, to 
allow Boston University to consummate a deal with a private company for the publicly 
acquired Framingham data.37 Disregard for public opinion led to suspicion of the 
private companies and their motives. Complications may arise when individual and 
community interests conflict. If the community consents to research participation, 
individuals may still refuse to participate; but if the community does not consent, then 
individuals who are identified because they are members of the community should not 
be approached for study enrolment. Issues of representation, social identity, internal 
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politics and cross-cultural differences abound.38 Yet, others have written that organized 
public involvement in priority setting could have a negative impact on research and 
development. The public could undermine the peer-review process by urging the 
government to support projects that have not been adequately reviewed or to stop valid 
research for political reasons.39 
Communities are cautious and sometimes skeptical about researchers because of 
scandals. Distrust amongst African-Americans may have been compounded by the 
shortcomings of the sickle cell screening programmes of the 1970s and more recently 
the Violence Initiative targeted at inner-city African American and Hispanic youth.40 
The use of blood samples from native people on Vancouver Island in Canada for 
undisclosed research projects is another example of reason for distrust.41 There are also 
general concerns that genetics may function to reaffirm perceived biological 
differences between populations, erect more barriers between groups, and create more 
avenues for discrimination.40 On the other hand, certain communities fear that they will 
be left out of potentially beneficial research, and they will therefore not be able to gain 
access to the technologies that result from genetic research.42 Yet, as discussed by 
Burgess and his colleagues,43 “population-wide genomics research and its ensuing 
developments (prevention through better screening and earlier treatment) may offer the 
most significant chance of benefit for individuals and populations that might otherwise 
find the health benefits of genome research inaccessible.” Protections for communities 
in genetic research represent another challenge for the research community and public 
policy-makers on how to enable innovation to occur in a manner which is both ethical 
and commands broad social and cultural acceptability.44, 45 
The recruitment of thousands of individuals for large-scale genetic databases calls 
for in-depth knowledge of the socio-cultural perceptions of the projects. Scientific 
aspects and issues need to be publicly discussed to help individuals in different 
communities understand the complexity of genetics research and subsequently to 
improve informed decision-making in these communities. Socio-cultural interests and 
concerns also need to be discussed to help researchers and policy-makers increase their 
understanding of the diversity of cultural beliefs and to develop a curriculum 
addressing culturally sensitive issues. Obtaining a community’s point of view cannot 
be achieved simply through information sessions.46, 47 As has been mentioned before, 
aggregated individual opinions are not a sufficient measure of what will happen in the 
public sphere, due to the intensity of commitment and the degree of organization and 
resources that genetics research requires. The process of dialogue is a more effective 
manner by which communities can have their collective voices heard by researchers 
and policy-makers, and for a number of different reasons. First, as indicated above, 
representatives of the general public need to be informed on the issues to fully consider 
all angles before they can voice an informed opinion. Second, these representatives 
need to come together face-to-face to share and understand those with similar and 
conflicting interests and concerns in order to gain new perspectives on the potential 
benefits and dangers of research and technology.43 Through thoughtful discussion of 
the issues, people are able to clarify and verbalize their own values, attitudes and 
beliefs and examine those of others. They are then able to find alternative approaches 
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that are equitable while respecting ethical and cultural pluralism. Of course, the 
personal preferences of the citizenry may be shaped or influenced by racial or other 
prejudices.39 Inclusion of minority groups and those with disabilities in the deliberation 
process is therefore an important part of public involvement in the progress of large-
scale genetic databases.  
Taking into account the diversity of interests and concerns that exists between 
groups will ensure a fair representation of these groups and will certainly facilitate their 
involvement in genetics research. Since many of these populations have an ethnic or 
religious identity that might become associated with genetic knowledge or phenotypic 
predispositions, it could be very helpful to address their concerns as to the equitable 
distribution of research benefits. For instance, the province of Quebec includes more 
than 19 cultural communities.  
There is evidence that the Canadian public is generally very supportive of genetics 
research. Yet, knowledge and understanding remain modest.48 A more thorough study 
has been done in the UK and it provides a useful starting point.24,25 The need for 
improving social and cultural management of technological development is being 
increasingly recognized by scientists and policy-makers. Public consultation, 
community involvement and transparency of decision-making are taking hold in 
official discourse. As a consequence, in Quebec for instance, genetic databases are high 
on the policy agenda. The Quebec Commission on Ethics in Science and Technology 
has provided an opinion on ethical issues raised by genetic databases within a 
responsible and democratic framework.17 The Quebec Network of Applied Genetic 
Medicine, in its Statement on the Ethical conduct of Genetic Research in Populations,16 
also recommends that “the values and cultural worldviews of the population should be 
taken into account at every stage of the research.” It should be noted however that 
researchers are not required to consult the communities. In addition, while Institutional 
Review Boards (IRBs) often consider the implications of the research project for the 
community, community consultation is not required in the IRB approval process. There 
is no agreement on the ethical and policy goals that community consultation can 
achieve and which methods best address these particular goals. There is little 
agreement as to what should trigger community consultation, nor the standards by 
which oversight bodies should evaluate them.49 
 
Conclusion 
 
Recent professional guidelines stress the importance of community consultation and 
involvement in population genetics research.2,16,17 Given the importance of maintaining 
public trust in biomedical research and the growing concern about privacy, 
discrimination and stigmatization, it is essential to improve our understanding of 
cultural attitudes regarding DNA and data banking.27,50 From the moment scientists 
better understand socio-cultural interests and concerns surrounding genetics research, 
research protocols can be modified to be respectful of cultural customs and to allow a 
greater involvement with and leadership of the communities themselves. To that end, 
the community must be involved in the research process through a dialogue between 
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researchers and community members. The underlying rationale is that community 
members are able to identify risks themselves and, often, can develop ways to 
minimize those risks that outsiders cannot.44 Such involvement may also reveal where 
communities place large-scale genetic databases in their moral, spiritual or religious 
frameworks, as well as the ways in which the public is grouped. This is important 
because this information might be decisive for framing the future of genetics research.  
Examples from two Native American communities show that community 
consultation can be effective only if researchers respect the diverse moral and social 
arrangements of those populations, recognize diverse moral and social harms they 
could suffer as a result of their participation, and take steps to reduce research-related 
risks so that both participants and non-participants with a shared social identity are 
protected.44 Also, in a research study on social patterns in African-American and 
European-American attitudes on genetics,40 it has been shown that rapid advances in 
genetic information may simply occur faster than many people can process. In fact, 
with relatively little preparation to understand breakthroughs in genetic research, the 
general public has been given a considerable amount of scientific information on 
genetics over the last several years. Consequently, many people may not be ready to 
embrace genetics. It is possible that some of the new knowledge may contradict certain 
individuals’ and groups’ ideas regarding the etiologies of disease and other conditions. 
For others, the genetics revolution may undermine their world views about human 
nature and social identity. Yet generally, the public accepts genetic technology, uses it, 
and is excited about the deeper level of understanding of nature that this research 
affords. 
Moreover, in order for community consultation to be effective, steps must be taken 
to safeguard specific communities from becoming targets of discrimination.45 
Ethnicized social categories are increasingly highlighted. Researchers have discussed 
social mechanisms that underscore the use of genetics to maintain existing stratification 
relationships.51,52 When consulting communities, researchers have to address how 
developments in genetic technology may intersect with existing race and ethnic 
relations. The social construction of race involves some notion of genetic differences 
within populations, and fears have been expressed that genetics may function to 
reaffirm perceived biological differences within populations, increase barriers between 
groups, and create more avenues for discrimination.40 For instance, Furr showed that 
African-Americans were more likely to view genetics unfavorably when compared to a 
sample of European-Americans.40 These fears and perceptions could not be ignored 
when consulting with communities. 
Finally, consulting communities may be better achieved through a two-way 
communication between investigators and the community. Initiating a dialogue with 
the community is needed if we are to find out what people really think, and if we are 
truly to consider participants as partners.53 For instance, the CARTaGENE Project 
approach, through its different consultation methods, integrates an active and collective 
conception of citizenship, where preoccupations and interests of citizens are taken into 
account. CARTaGENE’s researchers acknowledge that the establishment of a long-
term partnership and the promotion of constructive dialogue necessitate that the public 
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be both well-informed and widely consulted. This dialogue and partnership approach, 
although not fully actualized in population genetics, is in line with efforts to project 
transparency and open-mindedness at all levels.54, 55 The partnership approach aims to 
favor values such as integrity, ethical pluralism, respect for others, and democracy.56,57 
In addition to facilitating the recruitment and involvement of participants, such an 
approach can also help to identify and minimize the risks associated with research. 
Hence, both researchers and participants have a mutual interest to work together as 
partners with the appropriate balance of input and responsibility from academia and the 
public.58, 59 
Community consultation does not guarantee prevention of harm. Yet, on the basis 
of research findings, open discussion creates a forum that allows a considered response 
from community members to scientific realities and potential outcomes of research. As 
Robert Maya recommends after reviewing the history of bovine spongiform 
encephalopathy, “consult widely and get the best people, but also make sure dissenting 
voices are heard; recognize and admit uncertainty; and above all, be open and publish 
all advice. Try to separate risk assessment from risk management, and aim at 
management that is proportional to the risk involved. Wherever possible, make the 
facts and uncertainties clear and leave it to individuals to choose.”59 
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Table 1: Comparison of four large-scale genetic databases 
 Iceland: 
Icelandic Health 
Sector Database 
Estonia: 
Estonian Genome 
Project 
UK: 
Biobank 
QC: 
CARTaGENE 
Research 
focus 
• genetic linkage 
analysis 
• association 
studies 
• genetic 
epidemiology 
• pharmaco-
genetics 
• gene hunting 
• public health 
• genetic 
epidemiology 
• pharmaco-
genetics 
 
• genetic 
epidemiology 
with specific 
attn to diseases 
of later life 
• public health 
• pharmaco-
genetics 
• not a gene 
hunting project 
• genetic variation 
• association 
studies 
• genetic 
epidemiology 
• public health 
• pharmaco-
genetics 
• not a gene 
hunting project 
Data • personal health 
information 
linked to 
genotypes and 
genealogies 
• retrospective 
• info kept for 
approx 12 years 
• personal health 
information 
linked to 
genotypes, 
clinical histories 
and geneologies 
• retrospective 
• info kept for 
approx 5 years 
• personal health 
information 
linked to 
genotypes 
• prospective 
(approx 30 
years) 
• personal health 
information 
linked to 
genotypes and 
genealogies 
• retrospective & 
prospective 
(approx 5 years) 
Size • 270,000 people 
including 
children and the 
deceased 
• whole population 
of Iceland 
• 1 million people 
including 
children 
• ¾ of population 
of Estonia 
• 500,000 
unselected 
adults aged 45-
69 years 
• 60-65,000 
randomly 
selected 
individuals aged 
25-74 years 
Established by • Iceland 
government 
• Estonian 
government 
• Estonian 
Genome 
Foundation 
• The Wellcome 
Trust 
• Medical 
Research 
Council 
• UK 
Department of 
Health 
• Genome Quebec 
•  Quebec Network 
of Applied 
Genetic 
Medicine 
• Ministère de la 
recherche et de la 
science et de 
technologie 
Oversight • Data Protection 
Commission 
• National 
Bioethics 
Committee 
Dedicated bodies: 
• monitoring 
committee 
• interdisciplinary 
ethics committee 
• Ethics 
Committee 
• Estonian 
Genome Project 
Foundation (non-
profit 
organisation 
established by 
Estonian 
government) 
Proposed: 
• centrally 
managed with 
project director 
responsible to 
funders 
• separate, 
independent 
committee 
responsible to 
public, 
research 
participants 
and other 
stakeholders 
Public & Social 
Aspects: 
• IPEG (Institute 
advised by 
independent 
scientific & 
ethics boards) 
Operation: 
• scientific 
steering 
committee 
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Operation • Research 
resource with 
exclusive license 
to deCODE 
Genetics 
• public research 
resource 
• public research 
resource 
• public research 
resource 
Access • Ministry of 
Health 
• by commercial 
subscription 
• no exclusivity of 
access 
• access granted to 
Estonian 
Genome 
Foundation 
authorised 
researchers & 
nonexclusive 
licence 
agreements with 
pharmaceutical 
& biotech 
companies via 
EGeen (for-profit 
subsidiary) 
• no exclusivity 
of access 
• approval of 
researchers by 
funding 
agencies’ 
mandates 
• no exclusivity of 
access 
• access granted to 
CARTaGENE 
authorised 
researchers 
Confidentiality • personal 
information 
encrypted 
• personal 
information 
encrypted 
• personal 
information in 
an 
“anonymised 
linked” format 
• data will not be 
accessible to 
the insurance 
industry or any 
other similar 
body 
• personal 
information 
double-coded 
Consent • medical records 
on database 
without consent 
• individuals must 
“opt-out” and be 
placed on an 
abstainers list to 
be excluded 
• collection of 
DNA samples by 
clinicians with 
informed consent 
• no consent for 
genealogies as in 
public domain 
• informed consent 
(in writing) for 
data and samples 
• informed 
consent (in 
writing) for 
data and 
samples 
• voluntary “opt-
in” approach 
• General/Blank
et consent or 
consent for 
each use still to 
be decided 
• informed consent 
(in writing) for 
data and samples 
• voluntary “opt-
in” approach 
• consent required 
for each further 
use 
Legislation • specific 
legislation: 
Health Sector 
Database Act 
1998 
• specific 
legislation: 
Human Genes 
Research Act 
2000 
• no specific 
legislation 
• covered by 
Data 
Protection Act 
1998, Human 
Rights Act 
1998 and 
common law 
• no specific 
legislation 
• covered by QC 
Civil Code & 
Acts under the 
Personal 
Information 
Access 
Commission 
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